Cargando…

Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor

We report the case of a 57-year-old female patient who presented with defective vision in the right eye due to large hemorrhagic pigment epithelial detachment with subretinal hemorrhage near the arcades with scattered retinal pigment epithelium (RPE) alteration at the macula and minimal vitreous hem...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Shreyas, Manayath, George J., Gajula, Shruthi, Narendran, Venkatapathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433040/
https://www.ncbi.nlm.nih.gov/pubmed/37602155
http://dx.doi.org/10.4103/ojo.ojo_281_22
_version_ 1785091562524377088
author Shah, Shreyas
Manayath, George J.
Gajula, Shruthi
Narendran, Venkatapathy
author_facet Shah, Shreyas
Manayath, George J.
Gajula, Shruthi
Narendran, Venkatapathy
author_sort Shah, Shreyas
collection PubMed
description We report the case of a 57-year-old female patient who presented with defective vision in the right eye due to large hemorrhagic pigment epithelial detachment with subretinal hemorrhage near the arcades with scattered retinal pigment epithelium (RPE) alteration at the macula and minimal vitreous hemorrhage inferiorly. The left eye showed right angle perifoveal dipping venule with RPE alteration temporal to the fovea, intraretinal RPE stellate plaque at the macula area. Multimodal imaging features including color fundus photo, red-free photograph, optical coherence tomography (OCT), enhanced depth imaging OCT, fundus fluorescein angiography, indocyanine green angiography, and OCT angiography were studied along with treatment response. One eye showed features of macular telangiectasia Type 2 (MacTel 2) with polypoidal choroidal vasculopathy (PCV) (hemorrhagic type) and the other eye showed features of MacTel 2 with pachychoroid pigment epitheliopathy. This report highlights the hitherto undescribed co-occurrence of MacTel 2 with bilateral pachychoroid and with unilateral hemorrhagic PCV in one eye and its favorable outcome with anti-vascular endothelial growth factor therapy.
format Online
Article
Text
id pubmed-10433040
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-104330402023-08-18 Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor Shah, Shreyas Manayath, George J. Gajula, Shruthi Narendran, Venkatapathy Oman J Ophthalmol Case Report We report the case of a 57-year-old female patient who presented with defective vision in the right eye due to large hemorrhagic pigment epithelial detachment with subretinal hemorrhage near the arcades with scattered retinal pigment epithelium (RPE) alteration at the macula and minimal vitreous hemorrhage inferiorly. The left eye showed right angle perifoveal dipping venule with RPE alteration temporal to the fovea, intraretinal RPE stellate plaque at the macula area. Multimodal imaging features including color fundus photo, red-free photograph, optical coherence tomography (OCT), enhanced depth imaging OCT, fundus fluorescein angiography, indocyanine green angiography, and OCT angiography were studied along with treatment response. One eye showed features of macular telangiectasia Type 2 (MacTel 2) with polypoidal choroidal vasculopathy (PCV) (hemorrhagic type) and the other eye showed features of MacTel 2 with pachychoroid pigment epitheliopathy. This report highlights the hitherto undescribed co-occurrence of MacTel 2 with bilateral pachychoroid and with unilateral hemorrhagic PCV in one eye and its favorable outcome with anti-vascular endothelial growth factor therapy. Wolters Kluwer - Medknow 2023-06-27 /pmc/articles/PMC10433040/ /pubmed/37602155 http://dx.doi.org/10.4103/ojo.ojo_281_22 Text en Copyright: © 2023 Oman Ophthalmic Society https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Shah, Shreyas
Manayath, George J.
Gajula, Shruthi
Narendran, Venkatapathy
Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor
title Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor
title_full Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor
title_fullStr Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor
title_full_unstemmed Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor
title_short Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor
title_sort co occurrance of macular telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433040/
https://www.ncbi.nlm.nih.gov/pubmed/37602155
http://dx.doi.org/10.4103/ojo.ojo_281_22
work_keys_str_mv AT shahshreyas cooccurranceofmaculartelangiectasiatype2withhemorrhagicpolypoidalchoroidalvasculopathyandresponsetoantivascularendothelialgrowthfactor
AT manayathgeorgej cooccurranceofmaculartelangiectasiatype2withhemorrhagicpolypoidalchoroidalvasculopathyandresponsetoantivascularendothelialgrowthfactor
AT gajulashruthi cooccurranceofmaculartelangiectasiatype2withhemorrhagicpolypoidalchoroidalvasculopathyandresponsetoantivascularendothelialgrowthfactor
AT narendranvenkatapathy cooccurranceofmaculartelangiectasiatype2withhemorrhagicpolypoidalchoroidalvasculopathyandresponsetoantivascularendothelialgrowthfactor